📰 2 sources covering this story

The HIV shot that could change medicine is facing its biggest test: Getting to patients

First covered 12 hrs ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

The HIV shot that could change medicine is facing its biggest test: Getting to patients
The HIV shot that could change medicine is facing its biggest test: Getting to patients
Trials of lenacapavir, a drug developed by Gilead Sciences, show the twice-a-year shot is almost 100% effective at preventing HIV infection. Ihsaan Haffejee / AFP via Getty Images Gilead's lenacapavir shows near 100% efficacy in preventing HIV with twice-yearly shots, reports The Telegraph. Some Latin American countri
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →